Kristina Schira

Kristina Schira

Auto-generated profile, based on publicly available information

Kristina Schira

Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, 8093 Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2023 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
SOSebastian Oehler
Sebastian Oehler
LLLaura Lucaroni
Laura Lucaroni
FMFrancesca Migliorini
Francesca Migliorini
AEAbdullah Elsayed
Abdullah Elsayed
LPLuca Prati
Luca Prati
GBGabriele Bassi
Gabriele Bassi

5 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
DPDimitar Petrov
Dimitar Petrov
LPLouise Plais
Louise Plais
KSKristina Schira
Kristina Schira
JCJunyu Cai
Junyu Cai
MKMichelle Keller
Michelle Keller
JSJörg Scheuermann
Jörg Scheuermann
Cyclic peptides constitute an important drug modality since they offer significant advantages over small molecules and macromolecules. However, access to diverse chemical sets of cyclic peptides is difficult on a large library scale. DNA-encoded Chemical Libraries (DELs) provide a suitable tool to obtain large chemical diversity, but cyclic DELs made by standard DEL implementation cannot efficiently explore their conformational diversity. On the other hand, dual-display Encoded Self-Assembling Chemical (ESAC) Libraries can be used for modulating macrocycle flexibility since the two displayed peptides can be connected in an incremental fashion. In this work, we construct a 56 million dual-display ESAC library using a two-step cyclization strategy. We show that varying the level of conformational restraint is essential for the discovery of specific ligands for the three protein targets thrombin, human alkaline phosphatase and streptavidin.

18 December 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
PMPeter Mayrhofer
Peter Mayrhofer
MAMarkus R. Anneser
Markus R. Anneser
KSKristina Schira
Kristina Schira
CSCarina A. Sommer
Carina A. Sommer
ITIna Theobald
Ina Theobald
Arne SkerraArne Skerra
Arne Skerra
Affinity chromatography is the method of choice for the rapid purification of proteins from cell extracts or culture supernatants. Here, we present the light-responsive Azo-tag, a short peptide comprising p-(phenylazo)-L-phenylalanine (Pap), whose side chain can be switched from its trans-ground state to the metastable cis-configuration by irradiation with mild UV light. Since only trans-Pap shows strong affinity to α-cyclodextrin (α-CD), a protein exhibiting the Azo-tag selectively binds to an α-CD chromatography matrix under daylight or in the dark but elutes quickly under physiological buffer flow when illuminating the column at 355 nm. We demonstrate the light-controlled single-step purification – termed Excitography – of diverse proteins, including enzymes and antibody fragments, without necessitating competing agents or harsh buffer conditions as normally applied. While affinity chromatography has so far been governed by chemical interactions, introducing control by electromagnetic radiation as a physical principle adds another dimension to this widely applied separation technique.

25 May 2022 in Chimia
Verified
Journal Article
Open access
PDF file
MKMichelle Keller
Michelle Keller
KSKristina Schira
Kristina Schira
JSJörg Scheuermann
Jörg Scheuermann
DNA-Encoded Chemical Libraries (DELs) have gained momentum over the recent years for the discovery of small-molecule ligands and the technology has been integrated in most of the larger pharmaceutical companies. With this perspective we would like to summarize the development of DEL technology and present some representative DEL-derived hits which may soon enter the pharmaceutical market.

23 June 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
SMSalvatore Mirabile
Salvatore Mirabile
GPGiovanna Pitasi
Giovanna Pitasi
SFSonia Floris
Sonia Floris
KSKristina Schira
Kristina Schira
LKLyna Khettabi
Lyna Khettabi
LLLaura De Luca
Laura De Luca
Tyrosinase inhibition represents an attractive challenge to fight skin hyperpigmentation for medicinal and cosmeceutical application. We have previously provided insights for the development of novel compounds with a specific shape and functional groups interacting with tyrosinases from distinct sources. We chose to employ the Agaricus bisporus tyrosinase (AbTYR) isoform as a cost-effective and rapid screening method prior to carrying out the assay toward human tyrosinase (hTYR). Through this approach, the inhibitor [4-(4-hydroxyphenyl)piperazin-1-yl](2-methoxyphenyl)methanone (MehT-3) has been identified as an effective inhibitor against both TYRs with potency comparable to that of the marketed inhibitor Thiamidol. Continuing our efforts, in this work we designed a focused small series of MehT-3 derivatives that were in silico predicted for their ability to occupy the cavity of AbTYR and hTYR; subsequently, we proceeded with the execution of a very simple and efficient synthetic procedure to obtain the designed compounds. As a result, we obtained potent AbTYR and hTYR inhibitors with affinity values ranging from 5.3 to 40.7 μM. Notably, compounds 2 and 3 emerged as the most promising candidates; they exhibited superior activity against hTYR and demonstrated low toxicity as effective antioxidant agents and sunscreen products. Overall, these achievements further strengthened our computational protocol, which could be effectively applied to develop newer tyrosinase inhibitors.